References
- Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):1–9.
- Khattar RS, Swales JD, Banfield A, et al. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 1999;100(10):1071–1076.
- Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282(6):539–546.
- Verdecchia P, Reboldi G, Porcellati C, et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol. 2002;39(5):878–885.
- Clement DL, De Buyzere ML, De Bacquer DA, Office versus Ambulatory Pressure Study Investigators, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407–2415.
- Paz MA, de-La-Sierra A, Sáez M, et al. Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement. Medicine (Baltimore). 2016;95(30):e4071.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA. Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127-248–e248.
- Williams B, Mancia G, Spiering W, ESC Scientific Document Group, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
- Egan BM, Kjeldsen SE, Grassi G, et al. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019;37(6):1148–1153.
- Koren G, Nordon G, Radinsky K, et al. Machine learning of big data in gaining insight into successful treatment of hypertension. Pharmacol Res Perspect. 2018;6(3):e00396.
- Sun J, McNaughton CD, Zhang P, et al. Predicting changes in hypertension control using electronic health records from a chronic disease management program. J Am Med Inform Assoc. 2014;21(2):337–344.
- Mohammadi R, Jain S, Agboola S, et al. Learning to identify patients at risk of uncontrolled hypertension using electronic health records data. AMIA Jt Summits Transl Sci Proc. 2019;2019:533–542.
- Lacson RC, Baker B, Suresh H, et al. Use of machine-learning algorithms to determine features of systolic blood pressure variability that predict poor outcomes in hypertensive patients. Clin Kidney J. 2019;12(2):206–212.
- Wong MKF, Hei H, Lim SZ, et al. Applied machine learning for blood pressure estimation using a small, real-world electrocardiogram and photoplethysmogram dataset. Math Biosci Eng. 2023;20(1):975–997.
- da Silva VJ, da Silva Souza V, Guimarães da Cruz R, et al. Commercial devices-based system designed to improve the treatment adherence of hypertensive patients. Sensors (Basel). 2019;19(20):4539.
- Duan T, Rajpurkar P, Laird D, et al. Clinical value of predicting individual treatment effects for intensive blood pressure therapy. Circ Cardiovasc Qual Outcomes. 2019;12:e005010.